Your browser is no longer supported. Please, upgrade your browser.
Ashland Global Holdings Inc.
Index- P/E34.52 EPS (ttm)2.80 Insider Own0.10% Shs Outstand57.00M Perf Week-8.60%
Market Cap5.58B Forward P/E17.45 EPS next Y5.54 Insider Trans-1.88% Shs Float56.72M Perf Month-7.03%
Income174.00M PEG3.63 EPS next Q0.87 Inst Own- Short Float5.12% Perf Quarter-1.25%
Sales2.11B P/S2.64 EPS this Y131.20% Inst Trans0.10% Short Ratio7.32 Perf Half Y10.07%
Book/sh48.28 P/B2.00 EPS next Y16.47% ROA3.30% Target Price122.78 Perf Year15.14%
Cash/sh3.64 P/C26.56 EPS next 5Y9.50% ROE7.30% 52W Range79.16 - 110.74 Perf YTD-10.26%
Dividend1.20 P/FCF14.49 EPS past 5Y21.30% ROI4.60% 52W High-13.19% Beta1.25
Dividend %1.24% Quick Ratio1.30 Sales past 5Y-6.90% Gross Margin31.80% 52W Low21.44% ATR2.26
Employees4100 Current Ratio1.80 Sales Q/Q8.70% Oper. Margin8.40% RSI (14)26.66 Volatility2.80% 1.95%
OptionableYes Debt/Eq0.72 EPS Q/Q71.60% Profit Margin10.50% Rel Volume0.82 Prev Close96.61
ShortableYes LT Debt/Eq0.58 EarningsFeb 01 AMC Payout31.20% Avg Volume396.59K Price96.13
Recom2.20 SMA20-7.44% SMA50-7.79% SMA2002.61% Volume304,317 Change-0.50%
Jan-20-22Downgrade Wells Fargo Overweight → Equal Weight $120 → $110
Nov-11-21Downgrade Monness Crespi & Hardt Buy → Neutral
Oct-13-21Initiated Mizuho Buy $116
Jul-30-21Upgrade JP Morgan Underweight → Neutral $90
Jun-18-21Initiated Stifel Buy $118
May-04-21Downgrade JP Morgan Neutral → Underweight $88 → $89
Mar-15-21Resumed Credit Suisse Outperform $103
Feb-05-21Reiterated Monness Crespi & Hardt Buy $88 → $100
Sep-22-20Initiated Evercore ISI In-line
Jul-30-20Reiterated Monness Crespi & Hardt Buy $80 → $88
May-07-20Upgrade JP Morgan Underweight → Neutral $68 → $62
Apr-17-20Reiterated Monness Crespi & Hardt Buy $88 → $80
Apr-13-20Upgrade BMO Capital Markets Market Perform → Outperform $87 → $75
Mar-23-20Downgrade Jefferies Buy → Hold
Jan-29-20Downgrade JP Morgan Neutral → Underweight $68
Nov-20-19Downgrade BMO Capital Markets Outperform → Market Perform
Oct-16-19Initiated Wells Fargo Outperform
Oct-14-19Upgrade Monness Crespi & Hardt Neutral → Buy $88
Jun-14-19Downgrade JP Morgan Overweight → Neutral $82
Dec-27-18Upgrade JP Morgan Neutral → Overweight
Jan-24-22 04:18AM  
Jan-19-22 09:07AM  
Jan-18-22 06:30AM  
Jan-14-22 12:53PM  
Jan-13-22 06:00PM  
Jan-12-22 09:26AM  
Dec-27-21 11:38PM  
Dec-11-21 11:11PM  
Dec-10-21 04:53AM  
Dec-01-21 09:00AM  
Nov-22-21 07:00AM  
Nov-10-21 10:10AM  
Nov-09-21 07:55PM  
Nov-01-21 07:00AM  
Oct-18-21 09:14AM  
Oct-11-21 06:36AM  
Oct-07-21 07:00AM  
Oct-01-21 08:02AM  
Sep-30-21 11:03AM  
Sep-27-21 07:15AM  
Sep-15-21 09:53AM  
Sep-08-21 07:00AM  
Sep-06-21 08:30AM  
Sep-03-21 07:09AM  
Sep-01-21 08:26AM  
Aug-31-21 04:03AM  
Aug-27-21 06:17AM  
Aug-26-21 11:31AM  
Aug-19-21 10:00AM  
Aug-18-21 05:00PM  
Aug-13-21 12:21PM  
Aug-05-21 07:30AM  
Aug-03-21 05:00PM  
Jul-28-21 05:00PM  
Jul-27-21 06:15PM  
Jul-21-21 01:41AM  
Jul-20-21 03:01PM  
Jul-19-21 06:00PM  
Jul-06-21 10:55AM  
Jun-29-21 08:26AM  
Jun-26-21 02:18PM  
Jun-11-21 10:34AM  
Jun-10-21 06:30AM  
Jun-09-21 11:10AM  
Jun-08-21 07:30AM  
Jun-06-21 03:11AM  
Jun-01-21 09:37AM  
May-25-21 05:00PM  
May-24-21 11:35AM  
May-21-21 10:22AM  
May-20-21 05:00PM  
Apr-30-21 05:00PM  
Apr-28-21 07:15PM  
Apr-26-21 08:56PM  
Apr-23-21 07:30AM  
Apr-22-21 07:30AM  
Apr-09-21 08:54AM  
Apr-07-21 06:53AM  
Apr-06-21 10:11AM  
Apr-01-21 10:10AM  
Mar-31-21 10:36AM  
Mar-30-21 10:35AM  
Mar-29-21 03:16PM  
Mar-26-21 10:02AM  
Mar-25-21 09:14AM  
Mar-24-21 09:55AM  
Mar-23-21 10:30AM  
Mar-22-21 09:23AM  
Mar-19-21 12:20PM  
Mar-18-21 11:06AM  
Mar-17-21 12:04PM  
Mar-16-21 12:44PM  
Mar-15-21 07:30AM  
Mar-12-21 12:00PM  
Ashland Global Holdings Inc. provides additives and specialty ingredients worldwide. It operates through Life Sciences; Personal Care & Household; Specialty Additives; and Intermediates and Solvents segments. The Life Sciences segment offers pharmaceutical solutions, including controlled release polymers, disintegrants, tablet coatings, thickeners, solubilizers, and tablet binders; nutrition solutions, such as thickeners, stabilizers, emulsifiers, and additives; and nutraceutical solutions comprising products for weight management, joint comfort, stomach and intestinal health, sports nutrition, and general wellness, as well as custom formulation, toll processing, and particle engineering solutions. The Personal Care & Household segment provides a range of nature-based, biodegradable, and performance ingredients; solutions for toothpastes, mouth washes and rinses, denture cleaning, and care for teeth; and household supplies nature-derived rheology ingredients, biodegradable surface wetting agents, performance encapsulates, and specialty polymers. The Specialty Additives segment offers rheology modifiers, foam control agents, surfactants and wetting agents, pH neutralizers, advanced ceramics used in catalytic converters, environmental filters, ingredients for the manufacturing of ceramic capacitors, plasma display panels and solar cells, ingredients for textile printing, thermoplastic metals, and alloys for welding. The Intermediates and Solvents segment produces 1,4 butanediol and related derivatives, including n-methylpyrrolidone. Ashland Global Holdings Inc. offers its products to customers in a range of consumer and industrial markets, such as architectural coatings, construction, energy, food and beverage, nutraceuticals, personal care, and pharmaceutical. The company was formerly known as Ashland Inc. and changed its name to Ashland Global Holdings Inc. in September 2016. Ashland Global Holdings Inc. was founded in 1924 and is based in Wilmington, Delaware.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
NOVO GUILLERMOChairman and CEODec 20Option Exercise104.01262,70434,438Dec 21 10:20 AM
NOVO GUILLERMOChairman and CEODec 15Option Exercise104.018,996935,67438,546Dec 16 02:44 PM
Drury EileenSr VP, Human ResourcesDec 01Option Exercise37.371,13042,2281,130Dec 03 03:15 PM
Winkler von Mohrenfels Petra YSr. VP, GC and SecretaryNov 17Option Exercise106.9357161,0574,230Nov 19 05:29 PM
WANG XIAOLANSr VP & Gen Mgr, Personal CareNov 17Option Exercise106.9362266,510622Nov 19 05:30 PM
NOVO GUILLERMOChairman and CEONov 17Option Exercise106.937,858840,25631,983Nov 19 05:27 PM
WILLIS J KEVINChief Financial OfficerNov 17Option Exercise106.932,524269,8915,317Nov 19 05:28 PM
MUSA OSAMA MSr. Vice PresidentNov 17Option Exercise106.931,396149,2747,600Nov 19 05:26 PM
CHONG MINSr VP & Gen Mgr, Spc AdditivesNov 17Option Exercise106.9362166,404830Nov 19 04:49 PM
KALYANA SWAMINATHAN ASHOKSr VP & Gen Mgr, Life SciencesNov 17Option Exercise106.9357161,057853Nov 19 04:50 PM
BONI ERIC NPrincipal Accounting OfficerNov 17Option Exercise106.9331934,11110,726Nov 19 04:49 PM
Winkler von Mohrenfels Petra YSr. VP, GC and SecretaryNov 15Option Exercise108.1720822,4993,692Nov 17 05:26 PM
WILLIS J KEVINChief Financial OfficerNov 15Option Exercise108.172,920315,8563,299Nov 17 05:04 PM
NOVO GUILLERMOChairman and CEONov 15Option Exercise108.174,675505,69525,572Nov 17 05:02 PM
MUSA OSAMA MSr. Vice PresidentNov 15Option Exercise108.171,277138,1336,354Nov 17 05:01 PM
BONI ERIC NPrincipal Accounting OfficerNov 15Option Exercise108.1732935,58810,456Nov 17 05:00 PM
MUSA OSAMA MSr. Vice PresidentOct 01Option Exercise37.372,00074,7406,576Oct 05 04:58 PM
WILLIS J KEVINChief Financial OfficerSep 10Sale94.301,104104,107825Sep 13 04:42 PM
WILLIS J KEVINChief Financial OfficerSep 03Option Exercise29.502,30768,0563,131Sep 08 05:55 PM
KALYANA SWAMINATHAN ASHOKSr VP & Gen Mgr, Life SciencesAug 03Option Exercise83.4126522,104365Aug 05 04:06 PM
BONI ERIC NPrincipal Accounting OfficerJun 03Sale93.882,429228,03510,146Jun 04 04:34 PM
BONI ERIC NPrincipal Accounting OfficerJun 02Option Exercise95.425,085485,21115,231Jun 04 04:34 PM
Winkler von Mohrenfels Petra YSr. VP, GC and SecretaryMar 29Option Exercise59.791,46087,2984,241Mar 31 04:39 PM